Skip to main content
Veterinary Medicines

Calphon vet. Injektionsvätska, lösning

Not authorised
  • Butafosfan
  • CALCIUM GLUCOHEPTONATE
  • Calcium gluconate monohydrate
  • Magnesium chloride hexahydrate

Product identification

Medicine name:
Calphon vet. Injektionsvätska, lösning
Active substance:
  • Butafosfan
  • CALCIUM GLUCOHEPTONATE
  • Calcium gluconate monohydrate
  • Magnesium chloride hexahydrate
Target species:
  • Cattle
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Butafosfan
    4.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • CALCIUM GLUCOHEPTONATE
    45.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate monohydrate
    190.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    60.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        no withdrawal period
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Authorisation status:
  • Surrendered
Authorised in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • PROVET S.A.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 10364
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 26/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."